“…Because of the physical proximity of the two genes, C2 and factor B may share common regulatory mechanisms. Downregulation of C2 can be explained by the unusual complement activation properties of atherogenic lipids; specifically, there is clear evidence that the alternative pathway is activated, but there is dependence on the classic pathway component, C1q, however, not involving antibodies (28). Further studies will need to be undertaken to address these findings.…”